Jansi Lakshmi Willoughby, MD - Medicare Pulmonary Disease in Roseville, MI

Jansi Lakshmi Willoughby, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Roseville, Michigan. She went to Wayne State University School Of Medicine and graduated in 2013 and has 11 years of diverse experience with area of expertise as Pulmonary Disease. She is a member of the group practice Pulmonary And Critical Care Associates Pc and her current practice location is 25689 Kelly Rd Ste 100, Roseville, Michigan. You can reach out to her office (for appointments etc.) via phone at (586) 445-5995.

Jansi Lakshmi Willoughby is licensed to practice in Michigan (license number 4301116853) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1235577669.

Contact Information

Jansi Lakshmi Willoughby, MD
25689 Kelly Rd Ste 100,
Roseville, MI 48066-4993
(586) 445-5995
(586) 585-1281



Physician's Profile

Full NameJansi Lakshmi Willoughby
GenderFemale
SpecialityPulmonary Disease
Experience11 Years
Location25689 Kelly Rd Ste 100, Roseville, Michigan
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jansi Lakshmi Willoughby attended and graduated from Wayne State University School Of Medicine in 2013
  NPI Data:
  • NPI Number: 1235577669
  • Provider Enumeration Date: 06/07/2013
  • Last Update Date: 07/13/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 6800193913
  • Enrollment ID: I20200713001949

Medical Identifiers

Medical identifiers for Jansi Lakshmi Willoughby such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1235577669NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0200XInternal Medicine - Critical Care Medicine 4301116853 (Michigan)Secondary
207RS0012XInternal Medicine - Sleep Medicine 4301116853 (Michigan)Secondary
207RP1001XInternal Medicine - Pulmonary Disease 4301116853 (Michigan)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ascension St John HospitalDetroit, MIHospital
Beaumont Hospital - Grosse PointeGrosse pointe, MIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Pulmonary And Critical Care Associates Pc054725060722

News Archive

CBP, FDA seize counterfeit, flavored e-cigarettes valued at over $719K

U.S. Customs and Border Protection officers at the Dallas Fort Worth International Airport working in conjunction with agents from the U.S. Food and Drug Administration announced today that they have seized 33,681 units of e-cigarettes with a Manufacturer's Suggested Retail Price of $719,453.

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

Writers and producers from The Soloist, "Grey's Anatomy," "United States of Tara," "90210," and others were honored by the Substance Abuse and Mental Health Services Administration (SAMHSA) for increasing awareness of mental health issues and the power of recovery at the 2009 Voice Awards last night. The event was hosted by Academy Award-winning actor and mental health consumer Richard Dreyfuss at Paramount Studios in Los Angeles.

Simcere Pharmaceutical Group subsidiary receives Chinese SFDA approval for Zanamivir

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of Influenza A and Influenza B. Zanamivir is marketed globally by GlaxoSmithKline under the trade name Relenza.

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jansi Lakshmi Willoughby allows following entities to bill medicare on her behalf.
Entity NamePulmonary & Critical Care Associates Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598700932
PECOS PAC ID: 0547250607
Enrollment ID: O20040512001399

News Archive

CBP, FDA seize counterfeit, flavored e-cigarettes valued at over $719K

U.S. Customs and Border Protection officers at the Dallas Fort Worth International Airport working in conjunction with agents from the U.S. Food and Drug Administration announced today that they have seized 33,681 units of e-cigarettes with a Manufacturer's Suggested Retail Price of $719,453.

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

Writers and producers from The Soloist, "Grey's Anatomy," "United States of Tara," "90210," and others were honored by the Substance Abuse and Mental Health Services Administration (SAMHSA) for increasing awareness of mental health issues and the power of recovery at the 2009 Voice Awards last night. The event was hosted by Academy Award-winning actor and mental health consumer Richard Dreyfuss at Paramount Studios in Los Angeles.

Simcere Pharmaceutical Group subsidiary receives Chinese SFDA approval for Zanamivir

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of Influenza A and Influenza B. Zanamivir is marketed globally by GlaxoSmithKline under the trade name Relenza.

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jansi Lakshmi Willoughby is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jansi Lakshmi Willoughby, MD
50505 Schoenherr Rd Ste 290,
Shelby Twp, MI 48315-3141

Ph: (586) 314-0080
Jansi Lakshmi Willoughby, MD
25689 Kelly Rd Ste 100,
Roseville, MI 48066-4993

Ph: (586) 445-5995

News Archive

CBP, FDA seize counterfeit, flavored e-cigarettes valued at over $719K

U.S. Customs and Border Protection officers at the Dallas Fort Worth International Airport working in conjunction with agents from the U.S. Food and Drug Administration announced today that they have seized 33,681 units of e-cigarettes with a Manufacturer's Suggested Retail Price of $719,453.

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

Writers and producers from The Soloist, "Grey's Anatomy," "United States of Tara," "90210," and others were honored by the Substance Abuse and Mental Health Services Administration (SAMHSA) for increasing awareness of mental health issues and the power of recovery at the 2009 Voice Awards last night. The event was hosted by Academy Award-winning actor and mental health consumer Richard Dreyfuss at Paramount Studios in Los Angeles.

Simcere Pharmaceutical Group subsidiary receives Chinese SFDA approval for Zanamivir

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of Influenza A and Influenza B. Zanamivir is marketed globally by GlaxoSmithKline under the trade name Relenza.

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Roseville, MI

Robert Lewis Marchese, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 25810 Kelly Rd, Suite 3, Roseville, MI 48066
Phone: 586-777-9724    Fax: 586-777-9725
Benjamin O Osowa, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18263 E 10 Mile Rd, Suite E, Roseville, MI 48066
Phone: 586-552-8696    Fax: 586-552-4404
Dr. Majid Alzagoum, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066
Phone: 586-776-8877    Fax: 586-776-3092
Dr. Wahed Ishaqsei, M.D.
Pulmonary Disease
Medicare: May Accept Medicare Assignments
Practice Location: 18263 E 10 Mile Rd, Suite D, Roseville, MI 48066
Phone: 586-778-4950    Fax: 586-778-4952
Dr. Mohamad K. Ajjour, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066
Phone: 586-776-8877    Fax: 586-776-3092
Dr. Ameer Abdulrazzak, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18001 E 10 Mile, Suite 1, Roseville, MI 48066
Phone: 586-218-5800    Fax: 586-218-5808
Dr. Madjid Mesgarzadeh, MD
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 25910 Kelly Rd, Suite B, Roseville, MI 48066
Phone: 586-772-3366    Fax: 586-772-3355

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.